KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $18.88 $18.88 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $18.88 $18.88
52 weeks $8.39 $19.12

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
Jun 28, 2019 $11.30 $11.82 $11.30 $11.77 2 937 705
Jun 27, 2019 $10.85 $11.36 $10.85 $11.30 1 357 185
Jun 26, 2019 $11.16 $11.27 $10.69 $10.78 854 319
Jun 25, 2019 $11.05 $11.28 $10.81 $11.04 1 231 536
Jun 24, 2019 $11.57 $11.64 $11.09 $11.20 956 163
Jun 21, 2019 $11.50 $11.68 $11.23 $11.60 1 262 683
Jun 20, 2019 $11.62 $11.78 $11.37 $11.54 746 077
Jun 19, 2019 $11.77 $11.88 $11.53 $11.55 897 772
Jun 18, 2019 $12.53 $12.53 $11.33 $11.73 1 734 552
Jun 17, 2019 $12.22 $12.51 $12.03 $12.45 976 662
Jun 14, 2019 $11.80 $12.38 $11.64 $12.04 655 072
Jun 13, 2019 $11.56 $11.87 $11.42 $11.85 339 266
Jun 12, 2019 $11.31 $11.52 $11.18 $11.49 250 813
Jun 11, 2019 $11.58 $11.70 $11.23 $11.34 447 561
Jun 10, 2019 $12.11 $12.22 $11.35 $11.42 712 196
Jun 07, 2019 $11.37 $12.12 $11.18 $12.05 922 852
Jun 06, 2019 $11.78 $11.81 $11.19 $11.27 916 385
Jun 05, 2019 $11.68 $11.78 $11.40 $11.70 772 186
Jun 04, 2019 $11.21 $11.65 $11.02 $11.61 891 490
Jun 03, 2019 $10.85 $11.08 $10.77 $11.00 484 042
May 31, 2019 $10.73 $11.01 $10.73 $10.82 690 892
May 30, 2019 $10.80 $11.14 $10.75 $10.97 890 832
May 29, 2019 $10.75 $10.87 $10.57 $10.71 737 930
May 28, 2019 $11.30 $11.62 $10.87 $10.89 1 053 201
May 24, 2019 $11.10 $11.23 $10.92 $11.06 486 044
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT